Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (23.454)

91

Real-world data of Brazilian adults with X-linked hypophosphatemia (XLH) treated with burosumab and comparison with other worldwide cohorts

enthalten in: Molecular genetics & genomic medicine | 2024

von Vaisbich, M. | de Cillo, A. | Silva, B. | +8

92

Anti-CD3 monoclonal antibodies in treatment of type 1 diabetes : a systematic review and meta-analysis

enthalten in: Endocrine | 2024

von Liu, Y. | Li, W. | Chen, Y. | +1

93

Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks : A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial

enthalten in: American journal of clinical dermatology | 2024

von Puig, L. | Costanzo, A. | de Jong, E. | +9

94

Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatment

enthalten in: Journal of cellular biochemistry | 2024

von Ahamed, A. | Samanta, A. | Alam, S. | +4

95

Better efficacy, lower recurrence rate and decreased CD8+TRM with guselkumab treatment for generalized pustular psoriasis : A prospective cohort study from China

enthalten in: Clinical immunology (Orlando, Fla.) | 2024

von Lu, J. | Huang, D. | Yang, N. | +7

96

Guidelines for outpatient administration of naxitamab : Experience from Atrium Health Levine Children's Hospital

enthalten in: Cancer medicine | 2024

von Trovillion, E. | Michael, M. | Jordan, C. | +4

97

A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity

enthalten in: Nature communications | 2024

von de Campos-Mata, L. | Trinité, B. | Modrego, A. | +22

98

A phase Ib study evaluating the safety and efficacy of IBI310 plus sintilimab in patients with advanced non-small-cell lung cancer who have progressed after anti-PD-1/L1 therapy

enthalten in: Cancer medicine | 2024

von Zhao, Y. | Chen, X. | Yao, J. | +12

99

Extending dupilumab dosing intervals in atopic dermatitis : A prospective observational study in a South European tertiary hospital

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Valente, C. | Farinha, P. | Duarte, B.

100

Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors

enthalten in: Journal for immunotherapy of cancer | 2024

von Patel, S. | Alonso-Gordoa, T. | Banerjee, S. | +11